MGMT and glioblastoma: In GBM patients with unmethylated O6-methylguanine-DNA-methyltransferase (MGMT) promoter, producing the DNA-repair enzyme, prognosis is even worse [methylated vs. unmethylated mOS is 21.7 vs. 12.7 months; (6)].